Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

NCT02603419 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to lack of recruitment.

Conditions

Hodgkins Lymphoma

Interventions

DRUG: Avelumab
DRUG: Avelumab
DRUG: Avelumab
DRUG: Avelumab
DRUG: Avelumab
DRUG: Avelumab

Sponsor

Pfizer